STEMWorkbench Editor Demo

Phantom limb pain is very common after limb amputation and is often difficult to treat. The motor cortex stimulation is a valid treatment for deafferentation pain that does not respond to conventional pain treatment, with relief for 50% to 70% of patients. This treatment is invasive as it uses implanted epidural electrodes. Cortical stimulation can be performed noninvasively by repetitive transcranial magnetic stimulation (rTMS). The stimulation of the hemisphere that isn't involved in phantom limb (unaffected hemisphere), remains unexplored. We report a case of phantom limb pain treated with 1 Hz rTMS stimulation over motor cortex in unaffected hemisphere. This stimulation produces a relevant clinical improvement of phantom limb pain; however, further studies are necessary to determine the efficacy of the method and the stimulation parameters.

1. Introduction

Phantom limb pain (PLP) is very common after limb amputation and has a reported incidence of up to 87% of amputees [1]. This type of pain can be difficult to treat and usually responds poorly to conventional pain treatments [2–4]. Conversely, the electrical stimulation of the primary motor cortex (M1) has proved to be an effective treatment for intractable deafferentation pain. This treatment started in 1990, and many patients have been treated up to now. The patients who have been operated on were suffering from poststroke pain (59%), trigeminal neuropathic pain, brachial plexus injury, spinal cord injury, peripheral nerve injury, and phantom limb pain [5]. This treatment consists in chronic motor cortex stimulation (MCS) through implanted epidural electrodes. It results invasive and outcome varies from patient to patient [6, 7]. Otherwise cortical stimulation can be performed non-invasively by transcranial magnetic stimulation (TMS). A number of studies have shown that a single session of repetitive transcranial magnetic stimulation (rTMS) can relieve pain transiently in some patients with chronic neuropathic pain [8–10]. Other studies have shown that the duration of pain relief can be extended by repeated application of rTMS every day for five days in patient with trigeminal neuralgia and poststroke pain syndrome [6] or for ten days in patients with fibromyalgia [11]. In contrast, one study failed to see any long-term therapeutic effect of three weeks daily parietal cortex rTMS in two patients with phantom limb pain [12]. The majority of studies apply high frequencies (>1) with pulses below motor threshold on motor cortical area corresponding to the hand of the painful side. The reason for this is twofold: epidural stimulation usually employs pulses below motor threshold at ~40 Hz. and a study shows that the applications of rTMS at high frequency is more effective than applications of rTMS at low frequency (≤1) in this area of stimulation [8]. However, the effect of stimulation in unaffected hemisphere for phantom limb pain remains unexplored. In other cases, like neglect or recovery in stroke, stimulation with low frequency rTMS in unaffected hemisphere have shown therapeutic properties [13, 14]. We report a case of phantom pain limb treated with 1 Hz stimulation over motor cortex in unaffected hemisphere.

2. Case Study

A 36-yr-old, right-handed man, who had had a motorbike accident ten years ago, had total surgical amputation of the left arm. At the time of his arrival to our institute, he had perception of phantom limb and was experiencing severe phantom limb pain. This perception and pain have existed immediately after the amputation. The perception of phantom limb was always in the same position near the chest with the hand partially closed near the shoulder. The patient experienced pain like paresthesia, dysaesthesia and burning sensation especially in phantom thumb, index and medium, and in the total phantom limb too. The pain was present every day, always in wakefulness but not in sleep. Such pain persisted during the day and sometime became very intense for some seconds. In the past, the patient tried antiepileptic drugs, tricyclic and SSRI antidepressant, anti-inflammatory-analgesics, and opioids in order to relieve the pain. At the time of his arrival to our institute, he was having the best therapy that gave a partial relief to the pain. The therapy consisted in methadone 30 mg/day and pregabalin 300 mg/day. Neurological examination showed miosis and light ptosis in left eye, like Bernard-Horner syndrome which has existed immediately after the amputation. The examination also showed tactile hypoesthesia in the surgical scar, while the tactile stimulation of the area near the scar increased the pain in the phantom limb. The tactile stimulation of the left side of the face increased the pain in the phantom limb too. Chest MRI and CT with contrast excluded a peripheral component of pain due to a concomitant lesion of the inferior brachial plexus. The patient gave the written informed consent. At the baseline, at the end of every week, for three weeks during treatment and at the end of every week for three weeks after treatment, the following tests were administered: Hamilton Rating Scale for Depression (HAM-D), Hamilton Rating scale for Anxiety (HAM-A), Mania Rating Scale (MRS), CORSI TEST, Phonemic Verbal Fluency, and Visual Analogue Scale (VAS) for pain-0 (no pain) and 10 (maximal pain). The percentage of pain level modification was calculated from the VAS score by the following equation (post.rTMS – pre.rTMS pain scores) × 100/(pre.rTMS pain scores). Figure 1 below shows the reduction in percentage of pain in time. Clinical Global Impression-Improvement scale (CGI-I) was evaluated at the end of the third week of treatment. rTMS sessions were conducted in a laboratory staffed by physicians certified in basic life support and trained in the prompt recognition and treatment of seizures and other medical emergencies. Repetitive TMS was administered using a MAGSTIM rapid magnetic stimulator (Magstim Company, Ltd., Whitland, U.K.). We used a 70-mm figure eight-shaped coil. Patient sat in a reclining chair with a headrest for stabilization of the head and wore protective earplugs. Resting motor threshold (RMT) was defined as the intensity required eliciting at least five MEPs of 50 μV in peak-to-peak amplitude with 10 consecutive stimulations, when the coil was placed over the optimal position to activate the abductor pollicis brevis muscle in right hand based on electromyographic recording [15]. During treatment, the following were applied for 15 minutes, thirty 20-second trains at 1 Hz at 80% of RMT with a 10 seconds intertrain interval (a total of 600 stimuli per session were applied over the left motor cortex), these parameters are now widely considered safe [16]. A full course comprised fifteen daily sessions administered on weekdays, beginning on Monday. At all times, the coil was held tangentially to the scalp, with the handle pointing back and away from the midline at 45°. During every session of stimulation the patient had the sensation that the phantom limb went away from the shoulder towards mid-line in the direction of the pelvis, and the intensity of phantom limb pain reduced. The patient experienced no adverse event during or after rTMS application. At the end of the third week of treatment, the pain was reduced about 33.3% (see Figure 1), in fact VAS changed from 6 (pretreatment) to 4 (posttreatment), with CGI-I = 2 (much improved). In three weeks after treatment the percentage reduction of pain was reduced to 25% in the first week after the end of treatment and remained stable at about 16.6% in the second and in the third week after the end of treatment (Figure 1). During the three weeks of treatment and during the three weeks after treatment, Ham-D, Ham-A, and MRS all remained stable at ≤6. Also, score of the CORSI TEST remained stable at 5 and the score of the Phonemic Verbal Fluency remained stable at 17.6 and so these tests did not show cognitive impairment or improvement. RMT of unaffected hemisphere increased during treatment, in fact at baseline its value was 84% of Maximum Output of the Stimulator, after the first week of treatment, its value was 86% of Maximum Output of the Stimulator, and at the end of the second and third week of treatment its value was stable at 88% of Maximum Output of the Stimulator.